Dynamic Stereochemistry of Bioactive Compounds
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Natural Products Chemistry".
Deadline for manuscript submissions: closed (30 November 2022) | Viewed by 10546
Special Issue Editor
Interests: stereodynamic behavior; dynamic stereochemistry; NMR investigation; medicinal chemistry
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Since the first fundamental research of Pasteur, Le Belle, and Van't Hoff, which laid the foundation for modern stereochemistry, including dynamic stereochemistry, this field of knowledge has turned into a multidisciplinary science which is still actively developing. At present, the main one both in importance and in volume has become its area which studies the influence of the spatial structure on the rate and direction of chemical reactions, as well as on the manifested biological activity.
Today, dynamic stereochemistry plays a key role in almost all chemical disciplines, from asymmetric synthesis to the creation of modern drugs (medical chemistry), as well as nanomaterials. Considering the “dynamics” of its development, it is easy to see that the prospects for this direction are far from exhausted. The great interest and activity of researchers has led to the development of new methodologies in the most recent years and laid the fundamental foundations of promising areas of research for many decades to come. An additional incentive for the development of dynamic stereochemistry has been the rapid progress currently being observed in the block of sciences (biology, biochemistry, pharmacology, medical chemistry, etc.) studying the dependence of the therapeutic effect and side effects of drugs on steric factors, as well as the rapid development of chiral technologies in the pharmaceutical industry. Numerous studies in recent years clearly indicate the existence of a close relationship between biological activity and the spatial structure of biologically active compounds. For specialists working in the field of dynamic stereochemistry, it seems obvious that the stereoisomers of the same substance may have different biological activity or even different pharmacological uses. The activity, absorption, transport, biotransformation, and excretion of enantiomers can be fundamentally different. A large number of examples are known when one of the possible enantiomers of a drug compound is toxic or leads to undesirable side effects. Thus, serious malformations in children when taking thalidomide (also known as Contergan, sedative sleeping pills) at the end of the 1950s were caused by the teratogenic nature of its (S) enantiomer. This and other cases have led to increased requirements for the creation of enantiomerically pure compounds. The use of pharmacological agents in a pure spatial form can significantly increase the activity of the drug, reduce the dose, and reduce side effects. The chiral drug market has reached sales of over $90 billion. Current trends in this direction indicate that in the near future, medicinal compounds with internal asymmetry will be produced exclusively in enantiomerically pure form.
This Special Issue on “Dynamic Stereochemistry of Bioactive Compounds” is intended to attract researchers in this field who want to contribute their latest results to the forum of Molecules. It is my hope that a large number of interesting papers will be submitted that will reflect the potential and rapid development in this important area.
We cordially invite researchers working in this field to contribute original research articles, short communications, and critical review articles.
Dr. Vadim V. Negrebetsky
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Dynamics Stereochemistry
- Biological activity of stereoisomers
- Enantiomers of medicines
- Creation of modern medicines
- Control of the structure of molecules using external pulses (molecular motors)
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.